Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19

BACKGROUND: Uptake of COVID-19 bivalent vaccines and oral medication nirmatrelvir-ritonavir (Paxlovid) has remained low across the United States. Assessing the public health impact of increasing uptake of these interventions in key risk groups can guide further public health resources and policy. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hailey J., Tan, Sophia T., León, Tomás M., Jain, Seema, Schechter, Robert, Lo, Nathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246024/
https://www.ncbi.nlm.nih.gov/pubmed/37292707
http://dx.doi.org/10.1101/2023.05.18.23289533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246024/
https://www.ncbi.nlm.nih.gov/pubmed/37292707
http://dx.doi.org/10.1101/2023.05.18.23289533

Ejemplares similares